| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Current Ratio | 291 | % | +80.7% |
| Return On Equity | -490 | % | +39.5% |
| Return On Assets | -326 | % | +6.74% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Entity Common Stock, Shares Outstanding | 29.7M | shares | +215% |
| Common Stock, Shares, Outstanding | 29.7M | shares | +245% |
| Entity Public Float | 13.2M | USD | -8.16% |
| Common Stock, Value, Issued | 29.7K | USD | +245% |
| Weighted Average Number of Shares Outstanding, Basic | 20.3M | shares | +217% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Research and Development Expense | 22.7M | USD | +1.77% |
| General and Administrative Expense | 6.16M | USD | +17.5% |
| Operating Income (Loss) | -25.5M | USD | -4.28% |
| Nonoperating Income (Expense) | 54.3K | USD | +38.8% |
| Income Tax Expense (Benefit) | 0 | USD | |
| Net Income (Loss) Attributable to Parent | -25.3M | USD | -4.06% |
| Earnings Per Share, Basic | 0 | USD/shares | +93.7% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | 5.01M | USD | -41.7% |
| Accounts Receivable, after Allowance for Credit Loss, Current | 0 | USD | -100% |
| Assets, Current | 6.52M | USD | -40% |
| Property, Plant and Equipment, Net | 127K | USD | -26% |
| Other Assets, Noncurrent | 86.9K | USD | +22.4% |
| Assets | 6.73M | USD | -39.4% |
| Accounts Payable, Current | 976K | USD | -54.5% |
| Accrued Liabilities, Current | 848K | USD | +84.2% |
| Liabilities, Current | 1.82M | USD | -30.1% |
| Retained Earnings (Accumulated Deficit) | -146M | USD | -20.9% |
| Stockholders' Equity Attributable to Parent | 4.91M | USD | -42.3% |
| Liabilities and Equity | 6.73M | USD | -39.4% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Net Cash Provided by (Used in) Operating Activities | -5.97M | USD | -4.96% |
| Net Cash Provided by (Used in) Financing Activities | 7.91M | USD | |
| Net Cash Provided by (Used in) Investing Activities | -16.9K | USD | |
| Common Stock, Shares Authorized | 150M | shares | 0% |
| Common Stock, Shares, Issued | 29.7M | shares | +245% |
| Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | 1.93M | USD | |
| Deferred Tax Assets, Valuation Allowance | 36.8M | USD | +22.9% |
| Deferred Tax Assets, Gross | 36.8M | USD | +22.8% |
| Payments to Acquire Property, Plant, and Equipment | 16.9K | USD | |
| Property, Plant and Equipment, Gross | 939K | USD | +3.03% |
| Deferred Tax Assets, Operating Loss Carryforwards | 30.4M | USD | +19% |
| Depreciation, Depletion and Amortization | 16.9K | USD | -13.6% |